Applied DNA regains Nasdaq minimum bid price compliance; hearing cancelled

BNB PLUS CORP.

On July 2, 2025, Nasdaq notified Applied DNA it regained compliance with $1.00 minimum bid price rule (Rule 5550(a)(2)).
The July 15, 2025 hearing before the Nasdaq Hearings Panel has been cancelled.
Applied DNA's common stock will continue to be listed and traded on Nasdaq.

item 8.01

BNB PLUS CORP. filing history →

Source: SEC EDGAR

accession 0001104659-25-066078

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.